Federal grants to Neuropace Inc
Neuropace Inc in Mountain View, California received $9.7 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Extramural Research Programs in the Neurosciences and Neurological Disorders, with $3.8 million. In fiscal 2025 it was awarded $1.6 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$9.7 million
- Awards3
- Awarded in FY 2025$1.6 million
- Largest award$3.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $831,388 |
| FY 2022 | 1 | $2.6 million |
| FY 2023 | 1 | $3.0 million |
| FY 2024 | 2 | $1.7 million |
| FY 2025 | 2 | $1.6 million |
Programs that fund Neuropace Inc
| Program | Awards | Amount |
|---|---|---|
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $3.8 million |
| 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies | 1 | $3.4 million |
| Trans-NIH Research Support | 1 | $2.5 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $9.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Thalamocortical responsive neurostimulation for the treatment of lennox-gastaut syndrome - project summary / abstract lennox-gastaut syndrome (LGS) is a devastating form of childhood onset epilepsy with cognitive dysfunction and very frequent generalized onset seizures (GOS) often leading to injury. | Extramural Research Programs in the Neurosciences and Neurological Disorders | May 31, 2021 | $3.8 million |
| Thalamocortical responsive neurostimulation for the treatment of lennox-gastaut syndrome - project summary / abstract lennox-gastaut syndrome (LGS) is a devastating form of childhood onset epilepsy with cognitive dysfunction and very frequent generalized onset seizures (GOS) often leading to injury. | 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies | June 7, 2023 | $3.4 million |
| Thalamocortical responsive neurostimulation for the treatment of lennox-gastaut syndrome - project summary / abstract lennox-gastaut syndrome (LGS) is a devastating form of childhood onset epilepsy with cognitive dysfunction and very frequent generalized onset seizures (GOS) often leading to injury. | Trans-NIH Research Support | July 22, 2024 | $2.5 million |
Questions people ask
How much federal grant money does Neuropace Inc get?
$9.7 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Neuropace Inc the most?
The Department of Health and Human Services, with $9.7 million in 3 awards.
What is Neuropace Inc's largest federal grant?
$3.8 million under Extramural Research Programs in the Neurosciences and Neurological Disorders, with its first action in the period on May 31, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Neuropace Inc?
Its largest are Extramural Research Programs in the Neurosciences and Neurological Disorders, 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies and Trans-NIH Research Support.
Other grant recipients in Mountain View
- Bay Area Environmental Research Institute
- Mitra Future Technologies, Inc.
- Seti Institute
- City of Mountain View
- Enspectra Health, Inc.
- Claria Medical, Inc
- Eclipse Regenesis, Inc.
- Kinetic River Corp.
Largest federal grant recipients in California · Federal grants in California